EBC-1
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_2891
|
Homo sapiens (Human)
|
Lung squamous cell carcinoma
|
Population: Chinese; Taiwan., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8286010 PMID:9290701 PMID:10358721 PMID:10536175 PMID:11005564 PMID:12569360 PMID:14581340 PMID:15185009 PMID:15746151 PMID:16105816 PMID:17325662 PMID:19472407 PMID:20215515 PMID:20557307 PMID:22313637 PMID:22460905 PMID:24002593 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28676216 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778 PMID:38639832
|
Cancer cell line
|
Male |
EBC-1/original, EBC1 |
|
|
BTO:BTO_0003001, CLO:CLO_0050039, EFO:EFO_0003115, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:861, BioSample:SAMN03472045, BioSample:SAMN03472311, BioSample:SAMN10987674, cancercelllines:CVCL_2891, Cell_Model_Passport:SIDM00486, CGH-DB:185-1, CGH-DB:9172-4, ChEMBL-Cells:CHEMBL4295447, ChEMBL-Targets:CHEMBL4296411, CLS:305539, Cosmic:753554, Cosmic:801583, Cosmic:844845, Cosmic:876170, Cosmic:889089, Cosmic:917995, Cosmic:932929, Cosmic:946069, Cosmic:1048220, Cosmic:1219069, Cosmic:1239905, Cosmic:1571731, Cosmic:1656904, Cosmic:1694670, Cosmic:1802303, Cosmic:2060527, Cosmic:2125222, Cosmic:2546867, Cosmic:2645028, Cosmic:2668327, Cosmic-CLP:753554, DepMap:ACH-000563, EGA:EGAS00001000610, EGA:EGAS00001000978, FANTOM5_SSTAR:10486-107A9, GDSC:753554, GEO:GSM274671, GEO:GSM827595, GEO:GSM886993, GEO:GSM888062, GEO:GSM1374471, GEO:GSM1669749, IARC_TP53:11876, IARC_TP53:21134, JCRB:JCRB0820, LiGeA:CCLE_474, LINCS_LDP:LCL-1584, PharmacoDB:EBC1_315_2019, PRIDE:PXD030304, Progenetix:CVCL_2891, PubChem_Cell_line:CVCL_2891, RCB:RCB1965, TKG:TKG 0481, Wikidata:Q54831756 |
|
|
CVCL_2891 |
2026-08-15 04:27:27 |
15 |
ECC-1
Resource Report
Resource Website
50+ mentions
Contaminated Discontinued
|
RRID:CVCL_7260
|
Homo sapiens (Human)
|
Type I endometrial adenocarcinoma
|
Population: Japanese., Part of: ENCODE project common cell types; tier 3., Problematic cell line: Contaminated. Shown to be a Ishikawa 3-H-12 derivative (PubMed=22710073)..
|
PMID:10478797 PMID:16707768 PMID:20218740 PMID:22710073 PMID:23325432 PMID:25877200 PMID:33174010
|
Cancer cell line
|
Female |
ECC1, EnCa1 |
|
|
BTO:BTO_0005365, CLO:CLO_0037231, EFO:EFO_0005231, ATCC:CRL-2923, BioSample:SAMN03151801, BioSample:SAMN03472871, cancercelllines:CVCL_7260, Cosmic:1102375, Cosmic:1576451, Cosmic:1622895, Cosmic:2030461, ENCODE:ENCBS034DOC, ENCODE:ENCBS159ITB, ENCODE:ENCBS222DWG, ENCODE:ENCBS312UTV, ENCODE:ENCBS336PJO, ENCODE:ENCBS347ANJ, ENCODE:ENCBS624SHM, ENCODE:ENCBS670ZEX, ENCODE:ENCBS731RSG, ENCODE:ENCBS743VIZ, ENCODE:ENCBS758FSP, ENCODE:ENCBS767JJY, ENCODE:ENCBS862NRL, ENCODE:ENCBS896YZO, GEO:GSM843495, GEO:GSM843496, GEO:GSM923422, GEO:GSM923423, GEO:GSM923426, GEO:GSM923427, GEO:GSM1008574, GEO:GSM1008597, Lonza:1319, Wikidata:Q54831921 |
cvcl_d199 |
|
CVCL_7260 |
2026-08-15 04:27:29 |
90 |
EFM-192A
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1812
|
Homo sapiens (Human)
|
Breast carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10969801 PMID:19582160 PMID:22460905 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
EFM192A, EFM192 |
|
|
CLO:CLO_0002889, EFO:EFO_0006568, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03471045, BioSample:SAMN10988213, cancercelllines:CVCL_1812, Cell_Model_Passport:SIDM01002, Cosmic:1309000, Cosmic:1995391, Cosmic:2165004, Cosmic-CLP:1290798, DepMap:ACH-000117, DSMZ:ACC-258, DSMZCellDive:ACC-258, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1290798, GEO:GSM274641, GEO:GSM344365, GEO:GSM344415, GEO:GSM350532, GEO:GSM843498, GEO:GSM847316, GEO:GSM847470, GEO:GSM886998, GEO:GSM888067, GEO:GSM1172858, GEO:GSM1172950, GEO:GSM1421429, GEO:GSM1669755, IARC_TP53:28290, LiGeA:CCLE_198, LINCS_HMS:51114, LINCS_LDP:LCL-1478, PharmacoDB:EFM192A_322_2019, PRIDE:PXD030304, Progenetix:CVCL_1812, Wikidata:Q54832052 |
|
|
CVCL_1812 |
2026-08-15 04:27:33 |
9 |
EFO-27
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1192
|
Homo sapiens (Human)
|
Ovarian mucinous adenocarcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3476184 PMID:6405069 PMID:12661003 PMID:20164919 PMID:22460905 PMID:23415752 PMID:23839242 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30485824 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
EFO 27, EFO27 |
|
|
BTO:BTO_0002033, CLO:CLO_0002893, EFO:EFO_0006571, CLDB:cl1143, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:436, BioSample:SAMN03473290, BioSample:SAMN03473370, BioSample:SAMN10988215, cancercelllines:CVCL_1192, Cell_Model_Passport:SIDM01051, ChEMBL-Cells:CHEMBL3308134, ChEMBL-Targets:CHEMBL1075441, Cosmic:906852, Cosmic:1305326, Cosmic:1707565, Cosmic-CLP:906852, DepMap:ACH-000936, DSMZ:ACC-191, DSMZCellDive:ACC-191, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906852, GEO:GSM659375, GEO:GSM887001, GEO:GSM888070, GEO:GSM1340579, GEO:GSM1669757, IARC_TP53:21323, LiGeA:CCLE_238, LINCS_LDP:LCL-1521, PharmacoDB:EFO27_326_2019, PRIDE:PXD030304, Progenetix:CVCL_1192, PubChem_Cell_line:CVCL_1192, Wikidata:Q54832067 |
|
|
CVCL_1192 |
2026-08-15 04:27:34 |
1 |
EFM-19
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_0253
|
Homo sapiens (Human)
|
Breast ductal carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6589426 PMID:10969801 PMID:19582160 PMID:20164919 PMID:20215515 PMID:22460905 PMID:22585861 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
EFM19 |
|
|
BTO:BTO_0006447, CLO:CLO_0002888, EFO:EFO_0002175, MCCL:MCC:0000144, CLDB:cl1141, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:683, BioSample:SAMN03471840, BioSample:SAMN10988267, cancercelllines:CVCL_0253, Cell_Model_Passport:SIDM01056, ChEMBL-Cells:CHEMBL3308502, ChEMBL-Targets:CHEMBL1075439, Cosmic:906851, Cosmic:1603196, Cosmic:2165019, Cosmic-CLP:906851, DepMap:ACH-000330, DSMZ:ACC-231, DSMZCellDive:ACC-231, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906851, GEO:GSM344364, GEO:GSM344414, GEO:GSM350527, GEO:GSM783976, GEO:GSM843497, GEO:GSM847250, GEO:GSM847460, GEO:GSM886999, GEO:GSM888068, GEO:GSM1172949, GEO:GSM1669754, IARC_TP53:21321, IGRhCellID:EFM19, LiGeA:CCLE_105, LINCS_HMS:51113, LINCS_LDP:LCL-1311, PharmacoDB:EFM19_321_2019, PRIDE:PXD030304, Progenetix:CVCL_0253, PubChem_Cell_line:CVCL_0253, SLKBase:3411, Wikidata:Q54832051 |
|
|
CVCL_0253 |
2026-08-15 04:27:33 |
8 |
CHP 4 (W.W.)
Resource Report
Resource Website
Discontinued
|
RRID:CVCL_2779
|
Homo sapiens (Human)
|
Galactosemia
|
Population: African American.
|
PMID:1192846 PMID:6988327 PMID:11416159 PMID:25877200
|
Finite cell line
|
Male |
CHP 4, CHP #4, CHP4, GM00052, GM0052, GM052, GM-52, GM52 |
|
|
CLO:CLO_0002470, CLO:CLO_0002471, CLDB:cl774, CLDB:cl778, ATCC:CCL-133, BioSample:SAMN03470908, Coriell:GM00052, ECACC:90102537, IZSLER:BS CL 17, Wikidata:Q54813258 |
|
|
CVCL_2779 |
2026-08-15 04:20:51 |
0 |
CHP-126
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-304, RRID:CVCL_1123
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10079 PMID:17466 PMID:71759 PMID:1374683 PMID:6113887 PMID:6888561 PMID:7139592 PMID:11416159 PMID:11668190 PMID:15892104 PMID:16822308 PMID:20164919 PMID:22460905 PMID:25877200 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
CHP 126, CHP126, Children's Hospital of Philadelphia-126 |
DSMZ |
ACC-304 |
BTO:BTO_0005254, CLO:CLO_0002472, CLO:CLO_0050266, CLDB:cl776, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN01821621, BioSample:SAMN03473117, BioSample:SAMN10988481, cancercelllines:CVCL_1123, Cell_Model_Passport:SIDM00286, ChEMBL-Cells:CHEMBL3308252, ChEMBL-Targets:CHEMBL2366137, CLS:300432, Cosmic:688062, Cosmic:910567, Cosmic:1019935, Cosmic:2485942, Cosmic-CLP:910567, DepMap:ACH-000136, DSMZ:ACC-304, DSMZCellDive:ACC-304, EGA:EGAS00001000978, GDSC:910567, GEO:GSM563360, GEO:GSM886929, GEO:GSM887995, GEO:GSM1366403, GEO:GSM1669676, GEO:GSM3145586, GEO:GSM3145698, IARC_TP53:21225, LiGeA:CCLE_141, LINCS_LDP:LCL-1973, PharmacoDB:CHP126_198_2019, PRIDE:PXD030304, Progenetix:CVCL_1123, PubChem_Cell_line:CVCL_1123, RCB:RCB0486, Wikidata:Q54813263 |
|
|
CVCL_1123 |
2026-08-15 04:20:51 |
3 |
CHP-212
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1125
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Intermediate type (I-type) (PubMed=15720811)., Population: Caucasian., Part of: RAS genetic alteration cell panel (ATCC TCP-1031)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6113887 PMID:7139592 PMID:12068308 PMID:15720811 PMID:15892104 PMID:18724359 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28350380 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778 PMID:39255063
|
Cancer cell line
|
Male |
CHP 212, CHP212, NB9, NB-9, Children's Hospital of Philadelphia-212 |
|
|
CLO:CLO_0002467, CLO:CLO_0002473, CLO:CLO_0050261, EFO:EFO_0002133, CLDB:cl771, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2273, BioGRID_ORCS_Cell_line:595, BioSample:SAMN03472322, BioSample:SAMN03473208, BioSample:SAMN10988326, cancercelllines:CVCL_1125, Cell_Model_Passport:SIDM00910, ChEMBL-Cells:CHEMBL3308101, ChEMBL-Targets:CHEMBL1075423, Cosmic:724826, Cosmic:906820, Cosmic:920244, Cosmic:1161987, Cosmic:2131574, Cosmic-CLP:906820, DepMap:ACH-000120, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906820, GEO:GSM563361, GEO:GSM886930, GEO:GSM887996, GEO:GSM1366405, GEO:GSM1669678, GEO:GSM2371223, GEO:GSM2394381, IARC_TP53:21227, IGRhCellID:CHP212, LiGeA:CCLE_207, LINCS_LDP:LCL-1964, PharmacoDB:CHP212_200_2019, PRIDE:PXD030304, Progenetix:CVCL_1125, PubChem_Cell_line:CVCL_1125, RCB:RCB0477, Wikidata:Q54813267 |
|
|
CVCL_1125 |
2026-08-15 04:20:51 |
11 |
C2BBe1
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1096
|
Homo sapiens (Human)
|
Colon adenocarcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1506435 PMID:15868485 PMID:20164919 PMID:20570890 PMID:20606684 PMID:22460905 PMID:25388687 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28854368 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
C2BBE1, C2BBe 1, Caco-2/BBe 1, Caco-2/BBe, Caco-2BBe, Caco-2BBE, Caco-2 BBe, Caco2-BBE, Caco2BBe, Caco2BBE, CACO2BBE, BBE, Caco-2 Brush Border expressing 1 |
|
|
BTO:BTO_0005156, CLO:CLO_0002108, EFO:EFO_0006546, MCCL:MCC:0000089, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2102, BCRC:60182, BCRJ:0270, BioGRID_ORCS_Cell_line:580, BioSample:SAMN03472296, BioSample:SAMN10987952, cancercelllines:CVCL_1096, Cell_Model_Passport:SIDM01233, ChEMBL-Cells:CHEMBL3308231, ChEMBL-Targets:CHEMBL2366283, ColonAtlas:C2BBE1, Cosmic:687516, Cosmic:910700, Cosmic:1479619, Cosmic-CLP:910700, DepMap:ACH-000009, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:910700, GEO:GSM886897, GEO:GSM887962, GEO:GSM1669635, IARC_TP53:21203, LiGeA:CCLE_083, LINCS_LDP:LCL-1296, PharmacoDB:C2BBe1_153_2019, PRIDE:PXD005235, PRIDE:PXD030304, Progenetix:CVCL_1096, PubChem_Cell_line:CVCL_1096, Sigma-Aldrich:MTOX1000CC, Wikidata:Q54808117 |
cvcl_0025 |
|
CVCL_1096 |
2026-08-15 04:19:52 |
20 |
Caco-2
Resource Report
Resource Website
5000+ mentions
|
RRID:CVCL_0025
|
Homo sapiens (Human)
|
Colon adenocarcinoma
|
Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257; PubMed=34339474)., Virology: Highly susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=15316659; PubMed=15731278)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: ENCODE project common cell types; tier 3., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AstraZeneca Colorectal cell line (AZCL) panel.
|
PMID:327080 PMID:833871 PMID:2914637 PMID:3349466 PMID:3518877 PMID:6935474 PMID:7459858 PMID:7764660 PMID:8253353 PMID:8508948 PMID:9294210 PMID:10092214 PMID:10612807 PMID:10737795 PMID:11414198 PMID:11416159 PMID:11668190 PMID:12584437 PMID:14599474 PMID:15316659 PMID:15731278 PMID:15868485 PMID:16418264 PMID:16854228 PMID:16957166 PMID:18258742 PMID:20570890 PMID:20606684 PMID:20831567 PMID:21607810 PMID:23272949 PMID:23932154 PMID:24042735 PMID:24755471 PMID:25485619 PMID:25841592 PMID:25877200 PMID:25926053 PMID:25944804 PMID:25960936 PMID:26537799 PMID:26589293 PMID:26869432 PMID:28196595 PMID:28683746 PMID:29101300 PMID:29787057 PMID:30894373 PMID:31068700 PMID:31981602 PMID:33389257 PMID:34339474
|
Cancer cell line
|
Male |
CaCo-2, CACO-2, Caco 2, CACO 2, CACO2, CaCo2, CaCO2, Caco2, Caco-2/ATCC, Caco-II |
|
|
BTO:BTO_0000195, CLO:CLO_0002172, CLO:CLO_0050627, EFO:EFO_0001099, MCCL:MCC:0000120, CLDB:cl614, CLDB:cl615, CLDB:cl616, CLDB:cl617, CLDB:cl618, CLDB:cl619, CLDB:cl621, CLDB:cl5174, Abcam:ab275464, AddexBio:C0009009/29, ArrayExpress:E-MTAB-2706, ATCC:HTB-37, BCRJ:0059, BioSample:SAMN03473140, BioSample:SAMN05292461, BioSample:SAMN10989600, cancercelllines:CVCL_0025, CCRID:1101HUM-PUMC000100, CCRID:1102HUM-NIFDC00087, CCRID:3101HUMSCSP5027, CCRID:3101HUMTCHu146, CCRID:4201HUM-CCTCC00153, CCRID:5301HUM-KCB07010YJ, CCTCC:GDC0153, Cell_Model_Passport:SIDM00891, ChEMBL-Cells:CHEMBL3307519, ChEMBL-Targets:CHEMBL614058, CLS:300137, ColonAtlas:CACO2, Cosmic:720340, Cosmic:873696, Cosmic:875297, Cosmic:876709, Cosmic:887244, Cosmic:889531, Cosmic:948127, Cosmic:948829, Cosmic:983736, Cosmic:995392, Cosmic:1043805, Cosmic:1122320, Cosmic:1132564, Cosmic:1132694, Cosmic:1184081, Cosmic:1187299, Cosmic:1310931, Cosmic:1466811, Cosmic:1479620, Cosmic:1524334, Cosmic:1552180, Cosmic:1676742, Cosmic:1708415, Cosmic:1803940, Cosmic:1933015, Cosmic:2036652, Cosmic:2145574, Cosmic:2156940, Cosmic:2301543, Cosmic:2301964, Cosmic:2667879, Cosmic:2800568, DepMap:ACH-000003, DSMZ:ACC-169, DSMZCellDive:ACC-169, ECACC:09042001, ECACC:86010202, EGA:EGAS00001000610, EGA:EGAS00001002554, ENCODE:ENCBS311PHE, ENCODE:ENCBS390JMI, ENCODE:ENCBS391ENC, ENCODE:ENCBS530YXL, ENCODE:ENCBS700RKG, ENCODE:ENCBS890JZY, FANTOM5_SSTAR:10513-107D9, FCS-free:192-2-378-1-3-3, GEO:GSM206450, GEO:GSM274711, GEO:GSM274712, GEO:GSM274725, GEO:GSM383861, GEO:GSM472900, GEO:GSM472933, GEO:GSM513908, GEO:GSM514182, GEO:GSM741244, GEO:GSM749689, GEO:GSM749691, GEO:GSM749748, GEO:GSM784006, GEO:GSM843481, GEO:GSM843482, GEO:GSM845394, GEO:GSM945162, GEO:GSM945203, GEO:GSM945206, GEO:GSM945236, GEO:GSM1006210, GEO:GSM1006211, GEO:GSM1006212, GEO:GSM1346866, GEO:GSM1374426, GEO:GSM1448160, GEO:GSM2549989, GEO:GSM7701359, GEO:GSM7701360, IARC_TP53:21749, IBRC:C10094, ICLC:HTL97023, IZSLER:BS TCL 87, KCB:KCB 200710YJ, KCLB:30037.1, LINCS_LDP:LCL-1170, Lonza:36, MeSH:D018938, MetaboLights:MTBLS227, MetaboLights:MTBLS328, NCBI_Iran:C139, PharmacoDB:Caco2_161_2019, PRIDE:PXD001550, PRIDE:PXD005354, PRIDE:PXD005355, PRIDE:PXD018357, PRIDE:PXD019645, PRIDE:PXD023760, Progenetix:CVCL_0025, PubChem_Cell_line:CVCL_0025, RCB:RCB0988, TOKU-E:762, Ubigene:YC-D003, Wikidata:Q5016050 |
|
|
CVCL_0025 |
2026-08-15 04:19:53 |
9197 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
ATCC Cat# HTB-47, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
ATCC |
HTB-47 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:56 |
278 |
CAL-120
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1104
|
Homo sapiens (Human)
|
Breast carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:20164919 PMID:20215515 PMID:22460905 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30613774 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
CAL 120, CAL120 |
|
|
CLO:CLO_0002179, EFO:EFO_0005356, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-6647, BioGRID_ORCS_Cell_line:166, BioSample:SAMN03472991, BioSample:SAMN03473555, BioSample:SAMN10989564, cancercelllines:CVCL_1104, Cell_Model_Passport:SIDM00940, ChEMBL-Cells:CHEMBL3308577, ChEMBL-Targets:CHEMBL1075405, Cosmic:906826, Cosmic:1995355, Cosmic:2164984, Cosmic-CLP:906826, DepMap:ACH-000212, DSMZ:ACC-459, DSMZCellDive:ACC-459, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906826, GEO:GSM274647, GEO:GSM274665, GEO:GSM344361, GEO:GSM344411, GEO:GSM783963, GEO:GSM827160, GEO:GSM843483, GEO:GSM847210, GEO:GSM847455, GEO:GSM886904, GEO:GSM887969, GEO:GSM1172944, GEO:GSM1669645, IARC_TP53:21208, LiGeA:CCLE_802, LINCS_HMS:51110, LINCS_LDP:LCL-1463, PharmacoDB:CAL120_165_2019, PRIDE:PXD030304, Progenetix:CVCL_1104, PubChem_Cell_line:CVCL_1104, SLKBase:3487, Wikidata:Q54808384 |
|
|
CVCL_1104 |
2026-08-15 04:19:56 |
20 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
ICLC Cat# HTL95029, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
ICLC |
HTL95029 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:56 |
278 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
DSMZ Cat# ACC-54, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
DSMZ |
ACC-54 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:56 |
278 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
BCRJ Cat# 0408, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
BCRJ |
0408 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:59 |
278 |
CAL-12T
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1105
|
Homo sapiens (Human)
|
Lung non-small cell carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1657424 PMID:2145926 PMID:2440566 PMID:18083107 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:29681454 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
Cal-12T, Cal.12T, CAL 12T, CAL12T, Cal12T, CAL 12, Centre Antoine Lacassagne-12T |
|
|
CLO:CLO_0002180, EFO:EFO_0006547, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473097, BioSample:SAMN10987846, cancercelllines:CVCL_1105, Cell_Model_Passport:SIDM00939, ChEMBL-Cells:CHEMBL3308132, ChEMBL-Targets:CHEMBL1075406, Cosmic:753540, Cosmic:1995356, Cosmic-CLP:753540, DepMap:ACH-000826, DSMZ:ACC-443, DSMZCellDive:ACC-443, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:753540, GEO:GSM784241, GEO:GSM827248, GEO:GSM886905, GEO:GSM887970, GEO:GSM1669646, IARC_TP53:21209, LiGeA:CCLE_097, LINCS_LDP:LCL-1603, PharmacoDB:CAL12T_166_2019, PRIDE:PXD030304, Progenetix:CVCL_1105, PubChem_Cell_line:CVCL_1105, Wikidata:Q54808385 |
|
|
CVCL_1105 |
2026-08-15 04:19:56 |
2 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
KCLB Cat# 30047, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
KCLB |
30047 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:59 |
278 |
CAL-54
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-365, RRID:CVCL_1111
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8868943 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
CAL 54, CAL54, Centre Antoine Lacassagne-54 |
DSMZ |
ACC-365 |
CLO:CLO_0002186, EFO:EFO_0002125, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473166, BioSample:SAMN10988487, cancercelllines:CVCL_1111, Cell_Model_Passport:SIDM00932, ChEMBL-Cells:CHEMBL3308346, ChEMBL-Targets:CHEMBL1075412, Cosmic:910952, Cosmic-CLP:910952, DepMap:ACH-000457, DSMZ:ACC-365, DSMZCellDive:ACC-365, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910952, GEO:GSM886910, GEO:GSM887976, GEO:GSM1669653, IARC_TP53:21212, IGRhCellID:CAL54, LiGeA:CCLE_129, LINCS_LDP:LCL-1757, PharmacoDB:CAL54_173_2019, PRIDE:PXD030304, Progenetix:CVCL_1111, PubChem_Cell_line:CVCL_1111, Wikidata:Q54808409 |
|
|
CVCL_1111 |
2026-08-15 04:19:56 |
1 |
Calu-6
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0236
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1855224 PMID:2388294 PMID:3129183 PMID:3335022 PMID:3518877 PMID:3940644 PMID:6148444 PMID:6935474 PMID:7459858 PMID:7834619 PMID:7972006 PMID:8385084 PMID:12068308 PMID:12794755 PMID:20164919 PMID:20215515 PMID:20679594 PMID:22460905 PMID:22961666 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28273808 PMID:29681454 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
CaLu-6, CALU-6, Calu.6, Calu 6, Calu6, CALU6, CaLu-06 |
|
|
BTO:BTO_0002235, CLO:CLO_0002193, EFO:EFO_0002152, MCCL:MCC:0000125, CLDB:cl636, CLDB:cl638, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-56, BioGRID_ORCS_Cell_line:587, BioSample:SAMN03473148, BioSample:SAMN10987791, cancercelllines:CVCL_0236, CancerTools:161924, CCRID:1101HUM-PUMC000813, CCRID:3101HUMTCHu144, Cell_Model_Passport:SIDM00921, ChEMBL-Cells:CHEMBL3307639, ChEMBL-Targets:CHEMBL614535, CLS:300135, Cosmic:724859, Cosmic:929969, Cosmic:933575, Cosmic:934466, Cosmic:934542, Cosmic:1071885, Cosmic:1089230, Cosmic:1146874, Cosmic:1176611, Cosmic:1434959, Cosmic:1995360, Cosmic:2668262, Cosmic-CLP:724859, DepMap:ACH-000264, DSMZ:ACC-734, DSMZCellDive:ACC-734, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:724859, GEO:GSM108805, GEO:GSM108806, GEO:GSM253341, GEO:GSM434325, GEO:GSM513938, GEO:GSM514319, GEO:GSM794263, GEO:GSM817065, GEO:GSM843487, GEO:GSM886916, GEO:GSM887982, GEO:GSM1374435, GEO:GSM1374436, GEO:GSM1669659, IARC_TP53:119, IARC_TP53:21265, ICLC:HTL97003, IGRhCellID:Calu6, KCLB:30056, LiGeA:CCLE_215, LINCS_LDP:LCL-1626, Lonza:1139, NCBI_Iran:C431, PharmacoDB:Calu6_180_2019, PRIDE:PXD025499, PRIDE:PXD030304, Progenetix:CVCL_0236, PubChem_Cell_line:CVCL_0236, Wikidata:Q54808427 |
|
|
CVCL_0236 |
2026-08-15 04:19:57 |
35 |
CAL-27
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1107
|
Homo sapiens (Human)
|
Tongue adenosquamous carcinoma
|
Population: Caucasian., Part of: OPC-22 oral and pharyngeal cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2145926 PMID:2440566 PMID:3181269 PMID:19631575 PMID:20014447 PMID:20164919 PMID:21868764 PMID:22460905 PMID:24201445 PMID:25275298 PMID:25485619 PMID:25877200 PMID:25888065 PMID:26589293 PMID:27108184 PMID:27397505 PMID:28196595 PMID:28476783 PMID:29156801 PMID:29770536 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:34977030 PMID:35839778 PMID:36912284
|
Cancer cell line
|
Male |
Cal-27, CAL 27, Cal 27, CAL27, Cal27, CAL-SCC-27, Centre Antoine Lacassagne-27 |
|
|
BTO:BTO_0000921, CLO:CLO_0002178, CLO:CLO_0002182, EFO:EFO_0006366, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2095, BCRJ:0326, BioGRID_ORCS_Cell_line:336, BioSample:SAMN03471886, BioSample:SAMN10987905, cancercelllines:CVCL_1107, CCRID:1101HUM-PUMC000338, CCRID:4201HUM-CCTCC00248, CCTCC:GDC0248, Cell_Model_Passport:SIDM00937, ChEMBL-Cells:CHEMBL3308098, ChEMBL-Targets:CHEMBL1075408, CLS:305029, Cosmic:686972, Cosmic:910916, Cosmic:1006469, Cosmic:1017793, Cosmic:1041674, Cosmic:1339913, Cosmic:1466800, Cosmic:1530734, Cosmic:1752762, Cosmic:2043896, Cosmic:2131842, Cosmic:2296292, Cosmic-CLP:910916, DepMap:ACH-000832, DSMZ:ACC-446, DSMZCellDive:ACC-446, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910916, GEO:GSM422868, GEO:GSM423671, GEO:GSM886907, GEO:GSM887972, GEO:GSM1374427, GEO:GSM1374428, GEO:GSM1519074, GEO:GSM1519075, GEO:GSM1519076, GEO:GSM1669648, IARC_TP53:17482, IGRhCellID:CAL27%20GSE9585, LiGeA:CCLE_698, LINCS_LDP:LCL-1215, PharmacoDB:CAL27_168_2019, PRIDE:PXD002132, PRIDE:PXD028810, PRIDE:PXD029420, PRIDE:PXD030304, Progenetix:CVCL_1107, PubChem_Cell_line:CVCL_1107, Wikidata:Q54808394 |
|
|
CVCL_1107 |
2026-08-15 04:19:59 |
368 |